Oppenheimer Issues Pessimistic Forecast for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX) had its target price lowered by research analysts at Oppenheimer from $7.00 to $6.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Oppenheimer’s target price would indicate a potential upside of 57.48% from the company’s previous close.

Separately, Wall Street Zen raised Bioceres Crop Solutions from a “sell” rating to a “hold” rating in a research note on Saturday, June 21st. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus price target of $8.38.

Bioceres Crop Solutions Trading Down 2.1%

Shares of BIOX stock opened at $3.81 on Tuesday. Bioceres Crop Solutions has a twelve month low of $3.51 and a twelve month high of $11.78. The stock has a market cap of $238.93 million, a price-to-earnings ratio of -27.21, a PEG ratio of 1.10 and a beta of 0.41. The company’s 50-day moving average price is $4.63 and its 200-day moving average price is $4.97. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.22.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its quarterly earnings results on Wednesday, May 21st. The company reported ($0.02) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.08. The business had revenue of $59.60 million during the quarter, compared to analysts’ expectations of $61.80 million. Bioceres Crop Solutions had a negative net margin of 2.14% and a negative return on equity of 2.37%. As a group, equities analysts predict that Bioceres Crop Solutions will post -0.05 earnings per share for the current year.

Institutional Trading of Bioceres Crop Solutions

Several institutional investors have recently added to or reduced their stakes in the stock. Avanza Fonder AB lifted its position in shares of Bioceres Crop Solutions by 62.9% during the second quarter. Avanza Fonder AB now owns 26,164 shares of the company’s stock worth $117,000 after purchasing an additional 10,099 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Bioceres Crop Solutions by 3,535.8% in the first quarter. Jones Financial Companies Lllp now owns 5,490 shares of the company’s stock valued at $25,000 after purchasing an additional 5,339 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Bioceres Crop Solutions by 9.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 823,916 shares of the company’s stock worth $3,761,000 after buying an additional 71,581 shares during the period. PDT Partners LLC acquired a new stake in Bioceres Crop Solutions during the 1st quarter worth approximately $81,000. Finally, Long Focus Capital Management LLC boosted its position in Bioceres Crop Solutions by 11.4% in the 1st quarter. Long Focus Capital Management LLC now owns 829,748 shares of the company’s stock valued at $3,788,000 after buying an additional 85,000 shares during the period. Institutional investors and hedge funds own 17.68% of the company’s stock.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.